Mobocertinib(TAK-788)

Modify Date: 2025-08-26 19:27:45

Mobocertinib(TAK-788) structure	Common Name	Mobocertinib(TAK-788)
	CAS Number	1847461-43-1	Molecular Weight	585.70
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₂H₃₉N₇O₄	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Mobocertinib(TAK-788)

Mobocertinib is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2].

Name	Mobocertinib

Description	Mobocertinib is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
References	[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). [2]. Landon J. DURAK, et al. Pharmaceutical salts of pyrimidine derivatives and method of treating disorders. WO2019222093A1.

Description

Mobocertinib is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> JAK/STAT Signaling >> EGFR

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR

References

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN).

[2]. Landon J. DURAK, et al. Pharmaceutical salts of pyrimidine derivatives and method of treating disorders. WO2019222093A1.